Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      IPA punches holes into drug pricing policy implementation

      IPA punches holes into drug pricing policy implementation

      supriya kashyap kashyap7 April 2017 10:28 AM IST
      New Delhi : A body of major domestic pharma firms, IPA has hit out at the government over drug price control issue, wondering if the country followed...
      Cardinal Health nears $6 billion deal for Medtronic unit: Sources

      Cardinal Health nears $6 billion deal for Medtronic unit: Sources

      supriya kashyap kashyap7 April 2017 10:25 AM IST
      U.S. drug distributor Cardinal Health is nearing a deal to acquire medical device maker Medtronic's medical supplies business for close to $6 billion,...
      Practo unveils its new brand identity

      Practo unveils its new brand identity

      supriya kashyap kashyap7 April 2017 9:25 AM IST
      Bengaluru : Practo, the leading healthcare platform, unveiled its new brand identity and positioning Your Home for Health. Practo’s platform is...
      Trump nominee to lead FDA questioned on ties to pharmacy industry

      Trump nominee to lead FDA questioned on ties to pharmacy industry

      supriya kashyap kashyap6 April 2017 12:19 PM IST
      Democratic senators questioned President Donald Trump's nominee to lead the U.S. Food and Drug Administration, Dr. Scott Gottlieb, over his ties to...
      USFDA issues 2 observations to Dr Reddy

      USFDA issues 2 observations to Dr Reddy's for Srikakulam plant

      supriya kashyap kashyap6 April 2017 12:17 PM IST
      New Delhi : Drug firm Dr Reddy's Laboratories said the US health regulator has issued two observations after inspection of its manufacturing plant at...
      PhD Chambers organise PharmaMED HD 2017 to identify bottlenecks in health sector

      PhD Chambers organise PharmaMED HD 2017 to identify bottlenecks in health sector

      supriya kashyap kashyap6 April 2017 9:26 AM IST
      New Delhi : PHD Chamber in association with Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India is organizing 5th...
      Testing BOTOX for Depression: Allergan moves to PHASE III trial

      Testing BOTOX for Depression: Allergan moves to PHASE III trial

      supriya kashyap kashyap6 April 2017 9:15 AM IST
      Allergan plc (AGN.N) said that its Botox blockbuster wrinkle treatment just missed achieving a significant improvement in treating depression in a...
      Corbus Pharma outlines US approval path for lead drug

      Corbus Pharma outlines US approval path for lead drug

      supriya kashyap kashyap6 April 2017 9:15 AM IST
      The U.S. Food and Drug Administration needs Corbus Pharmaceuticals to show positive data from only one late-stage study on its experimental treatment...
      Teva wins FDA approval for Huntingtons drug

      Teva wins FDA approval for Huntington's drug

      supriya kashyap kashyap5 April 2017 11:26 AM IST
      Israel-based Teva Pharmaceutical Industries Ltd said the U.S. Food and Drug Administration had approved its drug to treat chorea stemming from...
      Drug maker GSK recalling nearly 600,000 asthma inhalers in US

      Drug maker GSK recalling nearly 600,000 asthma inhalers in US

      supriya kashyap kashyap5 April 2017 11:21 AM IST
      GSK Plc is voluntarily recalling more than 593,000 Ventolin asthma inhalers from U.S. hospitals, pharmacies, retailers and wholesalers due to a defect...
      Cipla gets USFDA nod for generic HIV drug

      Cipla gets USFDA nod for generic HIV drug

      supriya kashyap kashyap5 April 2017 11:20 AM IST
      New Delhi : Drug major Cipla has received approval from the US health regulator for its generic Abacavir and Lamivudine tablets used for treatment of...
      Mallinckrodt to pay $35M in deal to end feds opioid probe

      Mallinckrodt to pay $35M in deal to end feds opioid probe

      supriya kashyap kashyap5 April 2017 9:21 AM IST
      A top maker of brand-name and generic narcotic painkillers has agreed to pay the U.S. government $35 million to resolve a probe of its distribution of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok